43
Participants
Start Date
June 30, 2007
Primary Completion Date
September 30, 2008
Study Completion Date
September 30, 2008
PF-00232798
Solution, 20 mg. once daily, 10 days
PF-00232798
Solution, 150 mg. once daily, 10 days
PF-00232798
Solution, 5 mg. once daily, 10 days
PF-00232798
Solution, 40 mg. once daily, 10 days
PF-00232798
Solution, 300 mg. once daily, 10 days
PF-00232798
Solution, 400 mg. once daily, 10 days
Pfizer Investigational Site, Cologne
Pfizer Investigational Site, Frankfurt am Main
Lead Sponsor
Pfizer
INDUSTRY